Walnut meal fermentation product with immune activity and preparation method and application thereof

Through improved bacterial breeding, red Ganoderma lucidum fermentation of walnut meal was used to prepare walnut meal fermentation substances with immune activity, which solved the problem of limited immune activity of walnut peptides by microbial fermentation method, significantly improved the immune function of mice, and broadened the Application scope of walnut meal.

CN118667904BActive Publication Date: 2024-11-15YUNNAN UNIVERSITY OF CHINESE MEDICINE
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202411147524.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-15
Estimated Expiration
2044-08-21

AI Technical Summary

Technical Problem

The immune activity of walnut polypeptides produced by microbial fermentation is limited, and the types and activities of walnut polypeptides fermented by different bacterial species are different, which limits its application scope.

Method used

Through improved strain breeding, walnut meal is fermented with Ganoderma lucidium to prepare walnut meal fermented substances with immune activity, thereby enhancing the immune activity and utilization value of walnut peptides. Specific steps include bacterial strain activation, liquid-solid fermentation, fermentation separation and peptide content determination. The obtained walnut meal fermentation contains 33.7% polypeptide, which can significantly enhance the immune function of mice.

Benefits of technology

It significantly improved the immune function of mice, including enhancing half of the hemolytic value, phagocytosis index and cytokine release, broadening the application range of walnut meal, and providing drugs and feeds for preventing, improving or treating immune depression.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118667904B_ABST
    Figure CN118667904B_ABST
Patent Text Reader

Abstract

The invention relates to the field of biomedicine, and specifically discloses a walnut meal fermentation product with immune activity, a preparation method and an application thereof. Aiming at the problem that the immune activity of walnut polypeptides currently produced by microbial fermentation is limited, walnut meal is used as a raw material and red ganoderma lucidum is inoculated for fermentation, and the supernatant is obtained by centrifugation after fermentation to obtain the walnut meal fermentation product. The immune activity of the walnut meal fermentation product is detected, and the half hemolysis value of immunosuppressed mice can be significantly improved, the release of cytokines IgG, IgM, and IgA can be promoted, and the immune function of mice can be enhanced, and the walnut meal fermentation product has good application prospects in the preparation of immune enhancement drugs and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biomedicine, and in particular to a walnut meal fermentation product with immune activity and a preparation method and application thereof. Background Art

[0002] The statements in this section merely provide background information related to the present disclosure and may not constitute prior art.

[0003] Walnut kernel is a Chinese medicinal material that can be used as both medicine and food. It is included in the Chinese Pharmacopoeia and has a wide range of medicinal value. The Compendium of Materia Medica records that walnut kernel can moisten blood vessels, benefit the three burners, nourish qi and blood, warm the lungs and moisten the intestines, and has the function of moistening dryness and regulating blood; the Chinese Pharmacopoeia records that walnut kernel is warm in nature, sweet in taste, has the effects of nourishing the kidney, warming the lungs, and moistening the intestines. It is mainly used for kidney yang deficiency, soreness of the waist and knees, impotence and spermatorrhea, asthenia and cough, dry intestines and constipation. Walnut kernel is rich in nutrients such as oil (about 60%~70%), protein (about 15%), carbohydrates, dietary fiber, vitamins and minerals, and functional ingredients such as melatonin, polyphenols, and flavonoids.

[0004] Strengthening scientific research on walnut functions and increasing walnut added value have important scientific and socio-economic significance for the healthy and sustainable development of the walnut industry.

[0005] Compared with walnut protein, its hydrolyzate walnut peptide has good characteristics such as high concentration, low viscosity, good solubility, strong reducing ability and relative stability to pH changes. At present, the main methods for preparing polypeptides are hydrolysis, separation and extraction, chemical synthesis, genetic recombination, microbial fermentation, etc. The separation and extraction method is limited by the content of food polypeptides, and its yield and productivity are not ideal. Chemical synthesis is mainly used to prepare short peptides, which has high cost and many side reactions. Genetic recombination is mainly used to prepare larger peptides, but its related technology is not yet mature. Microbial fermentation can make rational use of resources and is the most economical method, but it has strict requirements on the selection of microorganisms.

[0006] At present, the research on walnut peptides produced by microbial fermentation is mostly focused on the antioxidant activity of walnut peptides, and there are relatively few studies on immune activity. In addition, due to the dependence of microbial fermentation on bacterial species, the types and activities of walnut peptides produced by different bacterial species are different. Summary of the invention

[0007] The purpose of the present invention is to provide a walnut meal fermentation product with immune activity and a preparation method and application thereof in response to the problem that the immune activity of walnut polypeptides currently produced by microbial fermentation is limited, and by breeding improved strains, walnut polypeptides with immune activity are produced using walnut meal, thereby improving the utilization value and application scope of walnut meal.

[0008] The technical solution of the present invention is as follows:

[0009] A method for preparing a walnut meal fermentation product having immune activity comprises the following steps: using walnut meal as a raw material and inoculating red ganoderma lucidum ( Ganoderma lucidium ) for fermentation.

[0010] According to a preferred embodiment, a method for preparing a walnut meal fermentation product having immune activity specifically comprises the following steps:

[0011] S1: Red Ganoderma Lucidum ( Ganoderma lucidium ) Activation of bacteria: accurately weigh 2g cornmeal, 1g bran, 1g soybean meal, 2g glucose, 0.15g KH2PO4, 0.1g MgSO4, and 100ml water, mix them in a 250ml clean conical flask, sterilize them with high-pressure steam, and prepare a liquid-solid bacterial culture medium. In an ultra-clean workbench, use an inoculation shovel to dig a piece of culture medium with mycelium and insert it into the prepared conical flask culture medium, inoculate mycelium into the liquid-solid bacterial culture medium, seal it with eight layers of gauze after inoculation, and place it in a shaker for culture. Set the shaker conditions to 28°C and 150rpm / min, and culture and activate for 6 days;

[0012] S2: Liquid-solid fermentation: walnut meal is crushed and divided into conical bottles, and sterilized under high pressure at 121°C for 15 minutes to prepare a liquid-solid fermentation medium; the activated bacterial suspension is taken out from the clean bench and inoculated into the liquid-solid fermentation medium at a rate of 0.25-8%, the mixture is evenly mixed, and the suspension is fermented at 28°C for 6-16 days; in the solid-liquid fermentation medium, the ratio of walnut meal to sterile water is 1:4-9.

[0013] S3: Fermentation separation: After the fermentation is completed, the fermentation suspension is centrifuged at a speed of 3000-4000 rpm / min for 10 minutes. The supernatant is taken after centrifugation, filtered, vacuum-freeze-dried and preserved to obtain the walnut meal fermentation product.

[0014] According to a preferred embodiment, the following steps are also included:

[0015] S4: Determine the peptide content in the sample using the biuret method. Use 5% TCA to dilute the tetrapeptide standard solution to 0.0, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, and 1.8 mg / ml in sequence. Take 6 ml of the diluted standard solution of different concentrations, add 4 ml of biuret reagent, mix well on a vortex mixer, and measure the OD value at 540 nm. Use the peptide content as the horizontal axis and the absorbance as the vertical axis to make a standard curve.

[0016] Take 2.5ml of sample solution, add 2.5ml of 10% trichloroacetic acid (TCA) aqueous solution, mix evenly on a vortex mixer, let stand for 10min, then centrifuge at 4000r / min for 15min, transfer all the supernatant to a 50ml volumetric flask, and dilute to the mark with 5% trichloroacetic acid, shake well. Then take 6.0ml of the above solution and put it in another test tube, add 4.0ml of biuret reagent (biuret reagent preparation method: 1.5g copper sulfate pentahydrate, 6g potassium sodium tartrate, add 300ml 10% sodium hydroxide, dilute to 1L with water), mix evenly on a vortex mixer, measure the OD value at 540nm, and compare with the standard curve to obtain the polypeptide concentration C (mg / ml) in the sample solution, and calculate the polypeptide content in the sample. Sample determination: Take 2.5 ml of sample solution, add 2.5 ml of 10% trichloroacetic acid (TCA) aqueous solution, mix evenly on a vortex mixer, let stand for 10 minutes, then centrifuge at 4000 r / min for 15 minutes, transfer all the supernatant to a 50 ml volumetric flask, and dilute to the mark with 5% trichloroacetic acid, shake well. Then take 6.0 ml of the above solution and put it in another test tube, add 4.0 ml of biuret reagent (biuret reagent preparation method: 1.5 g copper sulfate pentahydrate, 6 g potassium sodium tartrate, add 300 ml of 10% sodium hydroxide, dilute to 1L with water), mix evenly on a vortex mixer, measure the OD value at 540 nm, and compare with the standard curve to obtain the polypeptide concentration C (mg / mL) in the sample solution to obtain the polypeptide content in the sample.

[0017] On the other hand, the present application also provides a walnut meal fermentation product with immune activity prepared by the preparation method of the walnut meal fermentation product with immune activity as described above.

[0018] According to a preferred embodiment, the walnut meal fermentation product promotes the release of cytokines and enhances the immune function of mice.

[0019] According to a preferred embodiment, the walnut meal fermentation product comprises the immune active peptides GAATK, LMVIL or VIPPR.

[0020] According to a preferred embodiment, low molecular weight polypeptides with a molecular weight of less than 3 kd have higher immunological activity.

[0021] On the other hand, the present application also provides a use of a walnut meal fermentation product having immune activity in the preparation of a drug for preventing, improving or treating immunosuppression.

[0022] On the other hand, the present application also provides an application of a walnut meal fermentation product having immune activity in the preparation of a feed for preventing, improving or treating immunosuppression.

[0023] Compared with the prior art, the present invention has the following beneficial effects:

[0024] 1. A method for preparing a walnut meal fermentation product with immune activity, which improves the efficiency of converting walnut protein into walnut polypeptide with immune activity by improving the fermentation strain, thereby improving the utilization value of walnut meal, broadening the application scope of walnut meal, further processing walnut meal, developing the value of walnut meal, and saving resources;

[0025] 2. A walnut meal fermentation product with immune activity, with a polypeptide content of 33.7%, can significantly increase the half hemolytic value and mouse phagocytic index α of immunosuppressed mice, promote the release of cytokines, and enhance the immune function of mice. It has a good immune-enhancing effect, and its immune effect is better than that of existing fermentation products. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 The effect of a walnut meal fermentation product with immune activity on the hemolytic value of immunocompromised mice;

[0027] Figure 2 The effect of walnut meal fermentation product with immune activity on the immune phagocytic ability of mice;

[0028] Figure 3 The effect of a walnut meal fermentation product with immune activity on serum immunoglobulin in immunocompromised mice; Figure 3 A is the effect of walnut meal fermentation on serum immunoglobulin IgG in immunocompromised mice; Figure 3 B is the effect of walnut meal fermentation on serum immunoglobulin IgM in immunocompromised mice. Figure 3 C is the effect of walnut meal fermentation on serum immunoglobulin IgA in immunocompromised mice;

[0029] Figure 4 The effect of walnut meal fermentation product with immune activity on serum cytokines in immunocompromised mice;

[0030] Figure 5 Effects of walnut meal fermentation products with different molar mass fractions on the phagocytosis of RAW264.7 macrophages;

[0031] Figure 6 Effect of walnut meal fermentation products with different molar mass fractions on RAW264.7 macrophage interleukin 6 ( Figure 6 A.IL-6) and tumor necrosis factor ( Figure 6 B. The effect of TNF-α;

[0032] Figure 7 Effects of active peptides GAATK, LMVIL, and VIPPR on the phagocytic ability of RAW264.7 macrophages;

[0033] Figure 8 Effects of active peptides GAATK, LMVIL, and VIPPR on the immune factors interleukin-6 (IL-6) and tumor necrosis factor (TNF-α) in RAW264.7 macrophages.

[0034] Note: Compared with the normal group, **** indicates extremely significant difference (p<0.0001); compared with the model group, ### indicates extremely significant difference (p<0.001), ## indicates extremely significant difference (p<0.01). DETAILED DESCRIPTION

[0035] The features and performance of the present invention are further described in detail below in conjunction with the examples. The following examples are used to illustrate the present invention, but are not intended to limit the scope of protection of the present invention, which is subject to the claims.

[0036] Unless otherwise specified, the experimental reagents and materials used in the embodiments of the present invention are all commercially available.

[0037] Unless otherwise specified, the technical means used in the embodiments of the present invention are all conventional means well known to those skilled in the art.

[0038] Note: Compared with the normal group, **** indicates extremely significant difference (p<0.0001); compared with the model group, ### indicates extremely significant difference (p<0.001), ## indicates extremely significant difference (p<0.01).

[0039] Example 1 Preparation of walnut meal fermentation product

[0040] The walnut meal fermentation product was prepared as follows:

[0041] S1: Red Ganoderma Lucidum ( Ganoderma lucidium ) Activation of the strain: accurately weigh 2g cornmeal, 1g bran, 1g soybean meal, 2g glucose, 0.15g KH2PO4, 0.1g MgSO4, and 100ml water, mix them in a 250ml clean conical flask, sterilize with high-pressure steam, and prepare a liquid-solid strain culture medium. In the clean bench, use an inoculation shovel to dig a small piece of culture medium with mycelium (10-15mm 3 ) were inoculated into the prepared conical flask liquid-solid culture medium, sealed with eight layers of gauze after inoculation, and placed in a shaker for culture. The shaker conditions were set at 28°C and 150 rpm / min, and the culture was activated for 6 days;

[0042] S2: Liquid-solid fermentation: the walnut meal was crushed and divided into conical bottles, and sterilized under high pressure at 121°C for 15 min to prepare a liquid-solid fermentation medium; the activated bacterial suspension was taken out from the clean bench and inoculated into the liquid-solid fermentation medium with an inoculation amount of 2.21%, and the mixture was mixed evenly and fermented at 28°C for 16 days; in the liquid-solid fermentation medium, the ratio of walnut meal to sterile water was 1:9.

[0043] S3: Fermentation separation: After the fermentation is completed, the fermentation suspension is centrifuged at a speed of 3000-4000 rpm / min for 10 minutes. The supernatant is taken after centrifugation, filtered, vacuum-freeze-dried and preserved to obtain the walnut meal fermentation product.

[0044] S4: Determine the peptide content in the sample using the biuret method. Use 5% TCA to dilute the tetrapeptide standard solution to 0.0, 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, 1.4, 1.6, and 1.8 mg / ml in sequence. Take 6 ml of the diluted standard solution of different concentrations, add 4 ml of biuret reagent, mix well on a vortex mixer, and measure the OD value at 540 nm. Use the peptide content as the horizontal axis and the absorbance as the vertical axis to make a standard curve.

[0045] Take 2.5ml of sample solution, add 2.5ml of 10% trichloroacetic acid (TCA) aqueous solution, mix evenly on a vortex mixer, let stand for 10min, then centrifuge at 4000r / min for 15min, transfer all the supernatant to a 50ml volumetric flask, and dilute to the mark with 5% trichloroacetic acid, shake well. Then take 6.0ml of the above solution and put it in another test tube, add 4.0ml of biuret reagent (biuret reagent preparation method: 1.5g copper sulfate pentahydrate, 6g potassium sodium tartrate, add 300ml 10% sodium hydroxide, dilute to 1L with water), mix evenly on a vortex mixer, measure the OD value at 540nm, and compare with the standard curve to obtain the polypeptide concentration C (mg / ml) in the sample solution, and calculate the polypeptide content in the sample. Sample determination: Take 2.5 ml of sample solution, add 2.5 ml of 10% trichloroacetic acid (TCA) aqueous solution, mix evenly on a vortex mixer, let stand for 10 minutes, then centrifuge at 4000 r / min for 15 minutes, transfer all the supernatant to a 50 ml volumetric flask, and dilute to the mark with 5% trichloroacetic acid, shake well. Then take 6.0 ml of the above solution and put it in another test tube, add 4.0 ml of biuret reagent (biuret reagent preparation method: 1.5 g copper sulfate pentahydrate, 6 g potassium sodium tartrate, add 300 ml of 10% sodium hydroxide, dilute to 1L with water), mix evenly on a vortex mixer, measure the OD value at 540 nm, and compare with the standard curve to obtain the polypeptide concentration C (mg / mL) in the sample solution to obtain the polypeptide content in the sample.

[0046] The detection showed that the polypeptide content in the walnut meal fermentation product was 33.7%.

[0047] Example 2 Effect of walnut meal fermentation on the half hemolytic value of immunocompromised mice

[0048] Immunosuppressed model mice were prepared, and the HC50 in the model group was significantly reduced compared with the normal group (p<0.0001), indicating that the model was successfully established.

[0049] The extracted walnut meal fermentation product was added to the mouse feed, and the mice were divided into a low-dose group (200 mg / kg·d), a medium-dose group (400 mg / kg·d) and a high-dose group (800 mg / kg·d) according to the amount of walnut meal fermentation product added.

[0050] Data Analysis:

[0051] like Figure 1 As shown, compared with the model group, the HC50 of mice in the low, medium and high dose groups of walnut meal fermentation were significantly increased (p<0.01), indicating that walnut meal fermentation can significantly increase the half hemolytic value of immunocompromised mice.

[0052] like Figure 2 As shown in the figure, the carbon particle clearance experiment was performed on each group of mice. Compared with the normal group, the phagocytic index α of the model group mice was significantly reduced (p<0.0001). Compared with the model group mice, the phagocytic index α of the mice in the low, medium and high dose groups of walnut meal fermentation products was significantly increased (p<0.001). This shows that walnut meal fermentation products can significantly improve the immune phagocytic ability of immunocompromised mice.

[0053] like Figure 3 middle Figure 3 A. Figure 3 B and Figure 3 As shown in Figure C, compared with the normal group, the levels of IgG, IgM, and IgA in the model group were significantly reduced (p<0.0001), indicating that the mouse immunosuppression model was successfully established. Compared with the model group, the levels of IgG, IgM, and IgA in the serum of mice in the low and medium dose groups of walnut meal fermentation were significantly increased (p<0.001), indicating that the appropriate concentration of walnut meal fermentation can increase the content of immunoglobulins in mouse serum, thereby improving the immune capacity of mice.

[0054] like Figure 4 As shown in the results, compared with the model group, the low-dose group of walnut meal fermentation products can reverse the decrease of TNF-α and IL-6 in the serum of mice induced by CTX, and it is significant (p<0.05). This shows that walnut meal fermentation products can promote the release of cytokines and enhance the immune function of mice, suggesting that walnut meal fermentation products have a good effect of enhancing immunity.

[0055] Example 3 Optimization of fermentation conditions for uniform experiment

[0056] The fermentation process parameters were optimized using uniform experiment, and the results are as follows:

[0057] Table 1 Uniform experimental design data

[0058]

[0059] According to the experimental data in Table 1, the regression equation of the effect of fermentation products on macrophage phagocytosis was obtained by quadratic polynomial stepwise regression analysis:

[0060] Y=2.0559-0.4731×X2-0.0621×X3×X3+0.0070×X1×X2+0.1308×X2×X3;

[0061] Where Y is the phagocytosis rate, X1 is the fermentation time, X2 is the inoculation amount, and X3 is the solid-liquid ratio.

[0062] Regression equation correlation coefficient R 2 =0.999, significant level p 2 =0.0222, indicating that the regression equation has good correlation and significance level. Therefore, the equation can be used to predict the optimal process conditions for walnut meal fermentation with red Ganoderma lucidum: fermentation time 16 days, inoculation amount 2.21%, and feed-liquid ratio 1:9.

[0063] Example 4 Analysis of the immunological activity of walnut meal fermentation products with different molecular weights

[0064] Separation and immunological activity analysis of molecular weight peptides from walnut meal fermentation products. Ultrafiltration was used to obtain molecular weight peptides of different molar masses, and then the effects on macrophage phagocytosis and the release of IL-6 and TNF-α were tested. Figure 5 and Figure 6 As shown in the figure, the results showed that compared with the control group, fermented products of different molar masses could improve the phagocytic ability of macrophages and the release of IL-6 and TNF-α to varying degrees, and the phagocytic ability and the release of IL-6 and TNF-α increased with the decrease of molar mass. Among them, the components less than 3kDa had the strongest phagocytic ability, with a phagocytic rate of up to 141.47%, with significant differences (p<0.01); the components less than 3kDa promoted the release of IL-6 and TNF-α significantly (p<0.05). This shows that GL-WP of different molar mass segments can activate immune response and enhance immunity by promoting the release of IL-6 and TNF-α by macrophages.

[0065] Primary structure and activity analysis of immune active peptides from walnut meal fermentation. HPLC-MS / MS was used for analysis, and search and analysis were performed through the data analysis software mascot and the protein library Uniprot database to obtain three peptides, whose amino acid sequences were GAATK (Gly-Ala-Ala-Thr-Lys), LMVIL (Leu-Met-Val-Ile-Leu), and VIPPR (Val-Ile-Pro-Pro-Arg), and their molar masses were 446, 603, and 580Da, respectively. The three peptides GAATK, LMVIL, and VIPPR obtained by the present invention were retrieved as new immune active peptides. The three synthesized peptides were used to detect the effects on the phagocytic ability of macrophages and the release of IL-6 and TNF-α. The results are as follows Figure 7 and Figure 8 As shown, the results showed that compared with the control group, the active peptides GAATK, LMVIL, and VIPPR could enhance the phagocytic ability of macrophages, among which LMVIL had the strongest phagocytic ability, with a phagocytic rate of up to 196.09%, which was significantly different from the normal group (100%) (p<0.01). Figure 8 The results showed that GAATK, LMVIL and VIPPR can promote the release of IL-6 and TNF-α by macrophages, and the promotion of IL-6 release is significant. This indicates that the active peptides GAATK, LMVIL and VIPPR can activate the immune response and enhance immunity by promoting the release of IL-6 and TNF-α by macrophages.

[0066] The above-mentioned embodiments only express the specific implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the protection scope of the present application. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the technical solution concept of the present application, and these all belong to the protection scope of the present application.

Claims

1. A method for preparing a walnut meal fermentation product having immune activity, characterized in that: The method comprises the following steps: using walnut meal as raw material and inoculating red ganoderma lucidum for fermentation; The specific steps include: S1: Activation of red ganoderma: prepare liquid-solid culture medium, inoculate mycelium in liquid-solid culture medium for activation by aseptic operation; S2: Liquid-solid fermentation: walnut meal is crushed and packaged, sterilized, and prepared into a liquid-solid fermentation medium, and activated bacteria are inoculated under sterile conditions, mixed and fermented uniformly; the activated bacteria are inoculated at an inoculum rate of 0.25%-8%, and the liquid-solid fermentation medium has walnut meal: sterile water = 1:4-9, and the fermentation time is 6-16 days; S3: separation of fermented product: after the fermentation is completed, the fermented suspension is centrifuged, the supernatant is taken, filtered, freeze-dried, and walnut meal fermented product is obtained. The walnut meal fermented product includes the immune active peptides GAATK, LMVIL or VIPPR.

2. The method for preparing a walnut meal fermented product with immune activity according to claim 1, characterized in that: The following steps are also included: S4: The polypeptide content in the sample was determined by the biuret method.

3. The method for preparing a walnut meal fermented product with immune activity according to claim 1, characterized in that: The centrifugation conditions of the fermentation suspension in step S3 are: centrifugation at a speed of 3000-4000 rpm / min for 10 minutes, and the supernatant is freeze-dried.

4. A walnut meal fermentation product with immune activity prepared by the method for preparing a walnut meal fermentation product with immune activity according to any one of claims 1 to 3, wherein the walnut meal fermentation product comprises the immune active peptide GAATK, LMVIL or VIPPR.

5. The walnut meal fermentation product with immune activity according to claim 4, characterized in that: The polypeptide content is 33.7%.

6. Use of the walnut meal fermentation product with immune activity as claimed in claim 5 in preparing feed.

Citation Information

Patent Citations

  • SOD (Super Oxide Dismutase) grape health care wine

    CN101862446A

  • Making method of glossy ganoderma health-care seasoning liquid

    CN105433343A

  • Food capable of enhancing human immunity and production method thereof

    CN106722954A

  • Preparation method of walnut glutinous rice cakes capable of alleviating weariness

    CN107594325A

  • Method of using medicinally and edibly homogenous fungus to ferment walnut green husks and fermentation product thereof and applications of the fermentation product

    CN107811279A